« Return to News | R&D Trends

PharmaNet, McGill to develop Canadian translational research facility

Thursday, September 15, 2011 10:52 AM

PharmaNet Development Group, the US-based clinical development services provider acquired by inVentiv Health, has teamed up with a Canadian research institute to set up what the company says will be the country’s first in-hospital translational medicine unit for phase I-IIa clinical trials, according to PharmaTimes.

PharmaNet’s local subsidiary, PharmaNet Canada, has signed a letter of intent with The Research Institute of McGill University Health Centre (RI MUHC) in Montreal for a joint venture to establish, manage and operate the facility at the Montreal General Hospital.

The translational medicine unit, which PharmaNet says will “transform” the way pivotal proof-of-concept studies are conducted, is expected to start operations in 2012. According to Riaz Bandali, president, early stage development for PharmaNet, the initiative “aligns PharmaNet’s and RI MUHC’s objectives of optimally developing innovative therapeutics for patients in need.”

Pharmaceutical and biopharmaceutical companies using the facility will have access to state-of-the-art capabilities, specialized scientific knowledge, a broad range of patients, and “unsurpassed” medical and clinical development expertise within a safe hospital environment, Bandali added.

RI MUHC director Dr Vassilios Papadopoulos cited the Institute’s medical and scientific leadership in the understanding of diseases such as cancer, respiratory illness and cardiovascular failure.  

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.